Search This Blog

Wednesday, July 24, 2019

Alexion Pharmaceuticals EPS beats by $0.30, beats on revenue

Alexion Pharmaceuticals (NASDAQ:ALXN): Q2 Non-GAAP EPS of $2.64 beats by $0.30; GAAP EPS of $2.04 beats by $0.28.
Revenue of $1.2B (+14.3% Y/Y) beats by $20M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)